Trial · NCT06173869
Outcomes16
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Oocytes Retrieved | On day of oocyte retrieval (up to 22 days after start of stimulation) | Oocytes retrieved | MEAN | |
| SECONDARY | Number of Follicles on Stimulation Day 6 and End-of-stimulation | Stimulation day 6 and end-of-stimulation (maximum stimulation day 20) | Follicles | MEAN | |
| SECONDARY | Serum Concentrations of Estradiol on Stimulation Day 6 and End-of-stimulation | stimulation day 6 and end-of-stimulation (maximum stimulation day 20) | pmol/L | MEAN | |
| SECONDARY | Serum Concentrations of Progesterone on Stimulation Day 6 and End-of-stimulation | stimulation day 6 and end-of-stimulation (maximum stimulation day 20) | nmol/L | MEAN | |
| SECONDARY | Number of Fertilised Oocytes | On day 1 after oocyte retrieval (up to 23 days after start of stimulation) | Fertilised Oocytes | MEAN | |
| SECONDARY | Fertilisation Rate | On day 1 after oocyte retrieval (up to 23 days after start of stimulation) | percentage of fertilised oocytes | MEAN | |
| SECONDARY | Number of Embryos (Total and Quality) | Day 3 after oocyte retrieval | Embryos | MEAN | |
| SECONDARY | Total Gonadotropin Dose | Up to 20 stimulation days | ug | MEAN | |
| SECONDARY | Number of Stimulation Days | Up to 20 stimulation days | days | MEAN | |
| SECONDARY | Positive βhCG (Positive Serum βhCG Test 13-15 Days After Transfer) Rate | 13-15 days after transfer | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Clinical Pregnancy (at Least One Gestational Sac 5-6 Weeks After Transfer) Rate | 5-6 weeks after transfer | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Vital Pregnancy (at Least One Intrauterine Gestational Sac With Fetal Heart Beat 5-6 Weeks After Transfer) Rate | 5-6 weeks after transfer | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Implantation Rate | 5-6 weeks after transfer | Total Number of gestational sacs (subject level) | percentage of embryos transferred | NUMBER |
| SECONDARY | Ongoing Pregnancy (at Least One Intrauterine Viable Fetus 10-11 Weeks After Transfer) Rate | 10-11 weeks after transfer | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Ongoing Implantation Rate (Number of Intrauterine Viable Fetuses 10-11 Weeks After Transfer Divided by Number of Embryos Transferred) | 10-11 weeks after transfer | Low starting dose: 10 μg FE 999049 or 150 IU GONAL-F, high starting dose: 15 μg FE 999049 or 225 IU GONAL-F | percentage of embryos transferred | NUMBER |
| SECONDARY | Early Ovarian Hyperstimulation Syndrome (OHSS), Late OHSS, and Total OHSS (All Overall and by Grade) | ≤9 days after triggering of final follicular maturation (early OHSS), >9 days after triggering of final follicular maturation until 21-28 days after last IMP dose or up to ongoing pregnancy 8-9 weeks after transfer in pregnant participants (late OHSS) | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06173869/outcomes